Protalix BioTherapeutics Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| BLACKROCK, INC. | 08/07/2026 | 4.05 M | $9.43 M | 11.88% | 5.06% |
| RENAISSANCE TECHNOLOGIES LLC | 08/13/2026 | 1.10 M | $2.55 M | -10.52% | 1.37% |
| STATE STREET CORP | 08/07/2026 | 983.58 K | $2.29 M | 1.11% | 1.23% |
| GEODE CAPITAL MANAGEMENT, LLC | 08/12/2026 | 980.00 K | $2.28 M | 13.26% | 1.23% |
| NORTHERN TRUST CORP | 08/13/2026 | 922.34 K | $2.15 M | 4.17% | 1.15% |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 08/13/2026 | 510.64 K | $1.19 M | 18.07% | 0.64% |
| STRATOS WEALTH PARTNERS, LTD. | 08/11/2026 | 500.00 K | $1.17 M | 0.00% | 0.63% |
| DIMENSIONAL FUND ADVISORS LP | 08/11/2026 | 493.42 K | $1.15 M | 66.22% | 0.62% |
| GOLDMAN SACHS GROUP INC | 08/14/2026 | 475.92 K | $1.11 M | 89.35% | 0.60% |
| MARSHALL WACE, LLP | 08/13/2026 | 452.76 K | $1.05 M | 100.00% | 0.57% |
| CITADEL ADVISORS LLC | 09/02/2026 | 334.23 K | $778.75 K | 100.00% | 0.42% |
| STRS OHIO | 07/30/2026 | 296.10 K | $689.91 K | 100.00% | 0.37% |
| BANK OF NEW YORK MELLON CORP | 08/06/2026 | 232.99 K | $542.87 K | 6.24% | 0.29% |
| MAIN STREET FINANCIAL SOLUTIONS, LLC | 08/07/2026 | 214.10 K | $498.85 K | 0.00% | 0.27% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 08/14/2026 | 196.10 K | $456.91 K | 11.04% | 0.25% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 08/14/2026 | 189.10 K | $440.60 K | 0.00% | 0.24% |
| HILLSDALE INVESTMENT MANAGEMENT INC. | 08/12/2026 | 185.71 K | $432.71 K | 100.00% | 0.23% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 08/14/2026 | 180.38 K | $420.29 K | 13.23% | 0.23% |
| SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. | 08/14/2026 | 180.38 K | $420.29 K | 100.00% | 0.23% |
| MILLENNIUM MANAGEMENT LLC | 08/14/2026 | 171.54 K | $399.68 K | 100.00% | 0.21% |
| AQR CAPITAL MANAGEMENT LLC | 08/14/2026 | 167.83 K | $391.04 K | 450.38% | 0.21% |
| LAZARD ASSET MANAGEMENT LLC | 08/14/2026 | 165.56 K | $385.76 K | 91.14% | 0.21% |
| UBS GROUP AG | 08/13/2026 | 138.65 K | $323.05 K | -47.79% | 0.17% |
| JPMORGAN CHASE & CO | 08/12/2026 | 132.99 K | $312.53 K | 319.73% | 0.17% |
| NUVEEN, LLC | 08/11/2026 | 90.19 K | $210.14 K | 0.00% | 0.11% |
| DEUTSCHE BANK AG\ | 08/07/2026 | 77.54 K | $180.66 K | 3.40% | 0.10% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 08/14/2026 | 71.60 K | $166.83 K | 19.93% | 0.09% |
| VANGUARD FIDUCIARY TRUST CO | 08/13/2026 | 70.28 K | $163.75 K | 10.93% | 0.09% |
| WELLS FARGO & COMPANY/MN | 08/14/2026 | 67.55 K | $157.39 K | 154.69% | 0.08% |
| BAILARD, INC. | 07/30/2026 | 61.10 K | $142.36 K | 100.00% | 0.08% |
| STATE OF WYOMING | 08/06/2026 | 59.18 K | $137.89 K | 100.00% | 0.07% |
| WINTON GROUP LTD | 08/07/2026 | 56.00 K | $130.48 K | 100.00% | 0.07% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 08/14/2026 | 53.48 K | $125.00 K | 0.00% | 0.07% |
| BANK OF AMERICA CORP /DE/ | 08/14/2026 | 51.90 K | $120.92 K | -34.37% | 0.06% |
| MORGAN STANLEY | 08/13/2026 | 51.68 K | $120.41 K | -82.88% | 0.06% |
| RHUMBLINE ADVISERS | 08/12/2026 | 46.22 K | $107.70 K | 0.89% | 0.06% |
| METLIFE INVESTMENT MANAGEMENT, LLC | 08/14/2026 | 45.50 K | $106.02 K | 4.13% | 0.06% |
| CITADEL ADVISORS LLC | 09/02/2026 | 45.20 K | $105.32 K | 3.43% | 0.06% |
| TWO SIGMA INVESTMENTS, LP | 08/14/2026 | 42.52 K | $99.06 K | 134.51% | 0.05% |
| FRANKLIN RESOURCES INC | 08/13/2026 | 41.31 K | $96.26 K | 100.00% | 0.05% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 08/14/2026 | 40.94 K | $95.40 K | -16.59% | 0.05% |
| PHOENIX HOLDINGS LTD. | 08/11/2026 | 40.00 K | $92.92 K | 0.00% | 0.05% |
| JANE STREET GROUP, LLC | 08/14/2026 | 39.30 K | $91.57 K | -32.24% | 0.05% |
| JANE STREET GROUP, LLC | 08/14/2026 | 36.90 K | $85.98 K | 16.40% | 0.05% |
| INVESCO LTD. | 08/14/2026 | 36.72 K | $85.55 K | -22.54% | 0.05% |
| CITIGROUP INC | 08/03/2026 | 34.69 K | $80.83 K | 1,072.72% | 0.04% |
| MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 08/14/2026 | 34.10 K | $79.45 K | 0.10% | 0.04% |
| NEW YORK STATE COMMON RETIREMENT FUND | 07/29/2026 | 31.10 K | $72.46 K | 0.00% | 0.04% |
| APTUS CAPITAL ADVISORS, LLC | 08/12/2026 | 27.97 K | $65.16 K | 2.70% | 0.04% |
| SMARTLEAF ASSET MANAGEMENT LLC | 08/12/2026 | 25.98 K | $61.04 K | 0.00% | 0.03% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Protalix BioTherapeutics Inc. institutional Ownership - FAQ's
During the previous two years, 129 institutional investors and hedge funds held shares of Protalix BioTherapeutics Inc.. The most heavily invested institutionals were:
BlackRock, Inc.: 4.05 M
RENAISSANCE TECHNOLOGIES LLC: 1.1 M
STATE STREET CORP: 983,582
GEODE CAPITAL MANAGEMENT, LLC: 979,995
NORTHERN TRUST CORP: 922,340
VANGUARD PORTFOLIO MANAGEMENT LLC: 510,639
18.32% of Protalix BioTherapeutics Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 15.56 M shares in the last 24 months. This purchase volume represents approximately $44.82 M in transactions.